Xeruborbactam Oral Prodrug

DRUG2 trials

Sponsors

Qpex Biopharma, Inc.

Conditions

Bacterial Infections

Phase 1

P1, DDI & MAD PK and Safety Study of Xeruborbactam Oral Prodrug in Combo With Ceftibuten in Healthy Participants

CompletedNCT06079775

Qpex Biopharma, Inc.Bacterial Infections

Start: 2024-01-30End: 2025-01-05Updated: 2025-12-12

PK & Safety Study of Xeruborbactam Oral Prodrug Combined With Ceftibuten in Participants With Renal Impairment

CompletedNCT06157242

Qpex Biopharma, Inc.Bacterial Infections

Start: 2024-11-10End: 2025-03-31Updated: 2025-05-14